The management of central venous access device (CVAD) is extremely difficult in babies and small infants (BSI)” Ohno et al (2016).
Abstract:
BACKGROUND: The management of central venous access device (CVAD) is extremely difficult in babies and small infants (BSI). We therefore compared the long-term results and complications of CVAD in BSI with those in children.
[ctt link=”586Tb” template=”1″]ReTweet if useful… Complication rates associated with central venous access devices in infants https://ctt.ec/586Tb+ @ivteam #ivteam[/ctt]
METHODS: One hundred and twenty patients were divided into two groups as follows: age 0.99). The CVAD remained in place for 627 ± 494 and 550 ± 414 days (P = 0.47) and was removed before treatment completion in five and in 14 patients in groups A and B, respectively (P = 0.54).
CONCLUSION: The clinical results for CVAD in BSI did not differ from those in children. CVAD are useful and safe for the treatment of BSI with serious diseases.
Reference:
Ohno, K., Nakaoka, T., Takama, Y., Higashio, A., Santo, K. and Yoneda, A. (2016) Implantable central venous access device in infants: Long-term results. Pediatrics international. 58(10), p.1027-1031.
doi: 10.1111/ped.12945.
Thank you to our partners for supporting IVTEAM
[slideshow_deploy id=’23788’]